Literature DB >> 21094448

MR imaging of hepatocellular carcinoma.

Gaurav Khatri1, Laura Merrick, Frank H Miller.   

Abstract

Hepatocellular carcinoma (HCC) is a common malignancy typically associated with chronic liver disease and is a leading cause of mortality among these patients. Prognosis is improved when detected early. MRI is the best imaging examination for accurate diagnosis. Although arterial enhancement with delayed washout, increased T2-weighted signal intensity, delayed capsular enhancement, restricted diffusion, and tumor thrombus are typical features, not all lesions demonstrate these findings. The radiologist must be familiar with these typical imaging characteristics, and less common appearances and associated findings of HCC, and must be able to differentiate them from those of lesions that mimic HCC. Knowledge of therapeutic options and how those are related to imaging findings is imperative to assist clinicians in managing these patients.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21094448     DOI: 10.1016/j.mric.2010.08.002

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  8 in total

1.  Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.

Authors:  Jiyoung Hwang; Young Kon Kim; Ji Hye Min; Seo-Youn Choi; Woo Kyung Jeong; Seong Sook Hong; Hyun-Joo Kim; Soohyun Ahn; Hyeon Seon Ahn
Journal:  Eur Radiol       Date:  2017-05-12       Impact factor: 5.315

Review 2.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

Review 3.  MRI features of hepatocellular carcinoma related to biologic behavior.

Authors:  Eun-Suk Cho; Jin-Young Choi
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

Review 4.  Hepatocellular Carcinoma and Diffusion-Weighted MRI: Detection and Evaluation of Treatment Response.

Authors:  Jill S Gluskin; Fabrizio Chegai; Serena Monti; Ettore Squillaci; Lorenzo Mannelli
Journal:  J Cancer       Date:  2016-07-13       Impact factor: 4.207

5.  Primary hepatic peripheral T-cell lymphoma mimicking hepatocellular carcinoma: a case report.

Authors:  Jisun Lee; Kil Sun Park; Min Ho Kang; Yook Kim; Seung-Myoung Son; Hanlim Choi; Jae-Woon Choi; Dong Hee Ryu
Journal:  Ann Surg Treat Res       Date:  2017-07-28       Impact factor: 1.859

Review 6.  How to Differentiate Borderline Hepatic Nodules in Hepatocarcinogenesis: Emphasis on Imaging Diagnosis.

Authors:  Hyun Jeong Park; Byung Ihn Choi; Eun Sun Lee; Sung Bin Park; Jong Beum Lee
Journal:  Liver Cancer       Date:  2017-03-09       Impact factor: 11.740

Review 7.  CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017-Can Things Be Put Together?

Authors:  Cosmin Caraiani; Bianca Boca; Vlad Bura; Zeno Sparchez; Yi Dong; Christoph Dietrich
Journal:  Biology (Basel)       Date:  2021-05-06

8.  Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas >5 cm Without Extrahepatic Metastases: An Imaging-Based Retrospective Study.

Authors:  Meng Li; Yongjie Xin; Sirui Fu; Zaiyi Liu; Yong Li; Baoshan Hu; Shuting Chen; Changhong Liang; Ligong Lu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.